MedTrace Logo

Evaluation of the Impact of Preoperative Pelvic Floor Exercise on Incontinence After Laser Enucleation of the Prostate: a Feasibility Study.

NCT07456345 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-12

No results posted yet for this study

Summary

The purpose of this study is to assess the acceptability and feasibility of including a pelvic floor muscle exercise program into the care provided to patients undergoing prostate enucleation, studying both patients and clinicians perpsectives. A second part of the study will be to compare two groups, one receiving pelvic floor muscle exercise before surgery and and the other receiving the standard treatment, which is surgery. We will evaluate patients' perceptions of integrating physiotherapy sessions before surgery and attempt to identify facilitators and barriers to pelvic floor muscle exercise among both patients and clinicians.

Conditions

  • BPH (Benign Prostatic Hyperplasia)
  • Incontinence, Urinary
  • HoLEP
  • Pelvic Floor Muscle Exercise

Interventions

OTHER

Pelvic Floor Muscle Exercise before and after surgery

Teaching pelvic floor physiotherapy exercises: * Theoretical part. * Practical part, including various modalities: Manual method, where the therapist inserts a finger or a probe into the rectum to apply resistance to the muscle while asking the patient to contract and then relax the pelvic floor. Hypopressive abdominals, which involve breathing exercises to strengthen the deep abdominal muscles and support internal organs. Biofeedback, which allows the patient to visualize real-time muscle contractions. Teaching through biofeedback enables a better assessment of pelvic floor muscle endurance and contraction quality, respiratory coordination, and correction of incorrect physical postures. All patients will be provided with illustrated instructions to continue the exercises on their own.

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Naeem Bohjani, MD · Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2026-04-30
Completion
2026-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07456345 on ClinicalTrials.gov